Ducommun Incorporated logo DCO - Ducommun Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 12
HOLD 8
SELL 0
STRONG
SELL
0
| PRICE TARGET: $152.33 DETAILS
HIGH: $175.00
LOW: $132.00
MEDIAN: $150.00
CONSENSUS: $152.33
DOWNSIDE: 12.68%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong
Trading 144.7% above fair value
Current Price $174.45
Bear Case $56.28 67.7% downside ($56.28 - $174.45) / $174.45 = -67.7% $2.33 × 18x + net cash
Fair Value $71.28 59.1% downside ($71.28 - $174.45) / $174.45 = -59.1% $2.33 × 22x + net cash
Bull Case $86.29 50.5% downside ($86.29 - $174.45) / $174.45 = -50.5% $2.33 × 26x + net cash

Adjust Assumptions

22.0x
2.33$

Key Value Driver

Through-cycle normalized EPS ($2.33)

Implied Market Multiple 74.9x

Plain-Language Summary

Our base-case estimate uses Normalized Earnings × Cycle Multiple. We then blend that result with the average analyst price target of $152.33 from 20 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $71.28 per share.

Warnings

This company has a built-in lending arm whose debt is mixed in with the main business. We capped the debt adjustment to avoid overstating what the core business owes.
Price-to-book value of 9.2x is above the normal range for this type of business (0.7x-2.0x). The stock may already price in a strong cycle.
Wall Street's average price target is $152.33 (from 20 analysts). Our estimate is 71% below the consensus -- consider that gap carefully.

Key Risks

  • Standard 10-year DCF produces unreliable terminal values for cyclicals
  • 'Cheap' P/E at cycle peak is the most common value trap — normalize first
  • Captive finance subsidiaries have different risk profiles from manufacturing